Skip to main content
TipRanks
Go Ultimate75% OFF

Spero Therapeutics (SPRO) Q1 2023 Earnings Report

605 Followers

SPRO Q1 2023 EPS Results

Actual EPS
-$0.25
Consensus EPS
-$0.33
Beat/Miss
Beat by +$0.08
One Year Ago EPS
-$1.01

SPRO Q1 2023 Revenue Results

Actual Revenue
$740.00K
Expected Revenue
$1.27M
Beat/Miss
Missed by -$527.00K
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q1 2023
Date
05/11/2023
Time
After Close
Conference Call
Thursday, May 11, 2023
SPRO Upcoming Earnings

Spero Therapeutics's next earnings date is estimated for April 1, 2027, based on past reporting schedules.

Q1 2023 Earnings Call Audio

SPRO Q1 2023 Earnings Call
0:00 / 0:00

Q1 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q1 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

SPRO Earnings History

SPRO earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Apr 01, 20272026 (Q4)-0.17--0.13――
Nov 12, 20262026 (Q3)-0.47-0.76-0.13-484.62% (-0.63)
Aug 12, 20262026 (Q2)―-0.16-0.03-433.33% (-0.13)
May 13, 20262026 (Q1)―-0.13-0.2548.00% (+0.12)
Mar 26, 20262025 (Q4)-0.200.53-0.38239.47% (+0.91)
Nov 13, 20252025 (Q3)-0.25-0.13-0.3259.38% (+0.19)
Aug 12, 20252025 (Q2)-0.38-0.03-0.3390.91% (+0.30)
May 13, 20252025 (Q1)-0.55-0.25-0.24-4.17% (-0.01)
Mar 27, 20252024 (Q4)-0.31-0.380.96-139.58% (-1.34)
Nov 14, 20242024 (Q3)-0.27-0.32-0.06-433.33% (-0.26)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed